mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.002 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.003 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.004 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.004 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
0.13 |
0.005 |